LSCM
EGRX

LaSalle Street Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

LaSalle Street Capital Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
2018
Q2 		$261K Sell
2018
Q1 		$267K Sell
2017
Q4 		$283K Buy
2017
Q3 		$273K Buy
2016
Q4 		– Sell
2016
Q3 		$299K Sell
2016
Q2 		$304K Buy